For the Inventor, By the Inventor

Enter assignee name

Daiichi Suntory Pharma Co., Ltd.

USPTO Granted Patents = 23

Forward Citations = 80

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Harukazu Fukami (7 out of 50 patents)

Akira Mizuno (7 out of 28 patents)

Makoto Shibata (6 out of 23 patents)

4. Norio Inomata (6 out of 23 patents)

5. Yoichi Nunokawa (5 out of 6 patents)

6. Tomoe Kamei (4 out of 8 patents)

7. Kyoko Nakanishi (3 out of 11 patents)

8. Kenji Suzuki (3 out of 15 patents)

9. Hirokazu Annoura (2 out of 18 patents)

10. Shigeki Tamura (2 out of 19 patents)

11. Tetsuo Shimamoto (2 out of 8 patents)

12. Tomoe Iwamori (2 out of 12 patents)

13. Takashi Nakatsuka (2 out of 12 patents)

14. Masayuki Saitoh (2 out of 16 patents)

15. Keisuke Suzuki (1 out of 76 patents)

23 patents: Sort by Forward Citations

1. 7122543 - Substituted benzoic acid derivatives having NF-κB inhibiting action (2006-10-17),

2. 7064124 - NF-κB inhibitor containing substituted benzoic acid derivative as active ingredient (2006-06-20),

3. 7057036 - Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action (2006-06-06),

4. 7049079 - Coupling factor 6 inhibitor and potentiator and use thereof (2006-05-23),

5. 7026293 - Treatment or prophylaxis of ischemic heart disease (2006-04-11),

6. 6943196 - NF-κB inhibitor comprising phenylmethyl benzoquinone as the active ingredient (2005-09-13),

7. 6921766 - Blood vessel lipid deposition-preventive agent comprising chymase-inhibitor (2005-07-26),

8. 6900202 - Di-substituted imineheterocyclic compounds (2005-05-31),

9. 6867297 - Process for synthesizing 4-substituted azetidinone derivatives (2005-03-15),

10. 6867214 - Quinazoline derivatives and pharmaceutical applications thereof (2005-03-15),

11. 6838470 - Arylpiperidinopropanol and arylpiprazinopropanol derivatives and pharmaceuticals containing the same (2005-01-04),

12. 6743913 - Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and &agr;-1-blocking action (2004-06-01),

13. 6734180 - NF-&kgr;B inhibitor comprising an indan derivative as an active ingredient (2004-05-11),

14. 6713634 - Pyrroloazepine derivatives (2004-03-30),

15. 6706865 - Process for preparing flavonoids (2004-03-16),

Daiichi Suntory Pharma Co., Ltd. is a leading pharmaceutical company based in Japan. With a strong focus on research and development, they strive to discover and develop innovative drugs to improve the health and wellbeing of people around the world. As a subsidiary of Suntory Beverage & Food Ltd., Daiichi Suntory Pharma combines the expertise of both companies to deliver advanced medical solutions and contribute to society's well-being.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

23 Patents

#1,091 in Tokyo

#2,645 in Japan

#26,820 in the World

Daiichi Suntory Pharma Co., Ltd.

Forward Citations = 80

38 inventors:

Harukazu Fukami (7 out of 50 patents)

Akira Mizuno (7 out of 28 patents)

Makoto Shibata (6 out of 23 patents)

4. Norio Inomata (6 out of 23 patents)

5. Yoichi Nunokawa (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…